PD-217,014
From Infogalactic: the planetary knowledge core
175px | |
Systematic (IUPAC) name | |
---|---|
(1α,3α,5α)-3-aminomethyl-bicyclo[3.2.0]heptane-3-acetic acid
|
|
Identifiers | |
CAS Number | 444088-20-4 ![]() |
PubChem | CID: 10313401 |
ChemSpider | 19264101 |
Chemical data | |
Formula | C10H17NO2 |
Molecular mass | 183.247 g/mol |
|
|
|
PD-217,014 is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2). It was developed as a potentially more potent successor to gabapentin and pregabalin, along with several other analogues such as atagabalin and 4-methylpregabalin, but while PD-217,014 produces visceral analgesic effects in animal studies with higher potency and efficacy than gabapentin, it was not developed further for clinical use because of its comparatively more complex synthesis, compared to other related analogues.[1]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ Ohashi K, Kawai M, Ninomiya N, Taylor C, Kurebayashi Y. Effect of a new alpha 2 delta ligand PD-217014 on visceral hypersensitivity induced by 2,4,6-trinitrobenzene sulfonic acid in rats. Pharmacology. 2008;81(2):144-50. PMID 17989503
Categories:
- Pages with reference errors
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Abandoned drugs
- Amino acids
- Analgesics
- Calcium channel blockers
- GABA analogues
- Pfizer
- Nervous system drug stubs